Ultrasound examination
Deviceintrauterine fetal pulmonary artery acceleration time to ejection time ratio measurement via ultrasound
NCT Number: NCT03008200
Fetal PATET ratio evaluation to predict neonatal RDS
Looking for future studies?
Notify Me115 patients were enrolled in this study.Population was recruited from singleton pregnancies beyond 27 weeks of gestation.All participants underwent a ultrasound examination to measure fetal pulmonary artery acceleration to ejection time ratio (PATET) by a single experienced clinician. After the delivery respiratory distress diagnosis made by a pediatrician who were blinded the doppler waveform measurements.Following the diagnosis, neonates divided into 2 groups as RDS (+) and RDS (-). In addition of RDS diagnosis, neonatal features like 1st and 5th minute APGAR scores, neonatal intensive care unit (NICU) admission and duration in NICU were also recorded. Afterwards all parameters were statistically analyzed if there is any significant differences between those two groups.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
intrauterine fetal pulmonary artery acceleration time to ejection time ratio measurement via ultrasound
Time frame: Ten months
The aim of this study is to obtain the effectiveness of fetal pulmonary artery acceleration time to ejection time ratio in fetal lung maturity evaluation
Kayseri Education and Research Hospital
Other Gov
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01517958
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Infant, Newborn, Diseases
New York, United States
View Trial DetailsNCT01511952
Female Urogenital Diseases and Pregnancy Complications, Infections
View Trial DetailsNCT01942473
Female Urogenital Diseases and Pregnancy Complications, Obstetric Labor Complications
Ulm, Germany
View Trial Details